Logo

Capsulomics: Stacey Gilbert, Lisa Kann

Aug 19, 2022

Capsulomics has appointed Stacey Gilbert as vice president of market access and reimbursement and Lisa Kann as vice president of product development and strategy.

Gilbert will lead efforts to optimize government and private companies' coverage, coding, and reimbursement for Capsulomics' testing portfolio. Before joining Capsulomics, she was the senior director of population health and director of market access strategy for Exact Sciences. She also has prior experience in sales and market access at Sankyo Pharma, CV Therapeutics, Gilead Sciences, Zoll LifeVest, SomnoMed, and Medac Pharma.

Kann was previously the director of lab planning and project management at Thrive Earlier Detection, which was acquired by Exact Sciences in 2021. She also was head of laboratory operations at Papgene, VP of laboratory operations at Personal Genome Diagnostics, scientist and manager at Genzyme Genetics, and principal scientist at Exact Sciences.

Breaking News
The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.